CAThrombosis.com is developed and funded by LEO Pharma as an educational resource.

CAThrombosis
LEO

YOUR EXPERT
CANCER-ASSOCIATED THROMBOSIS RESOURCE

www.cathrombosis.com
CAThrombosis Calender IconJANUARY 2017

Dear Subscriber

Welcome to the first issue of the eNewsletter from CAThrombosis.com for 2017. We hope you find it to be a useful way to keep up to date with the latest developments on the website, including recently added new resources and a video recording of a symposium on CAT held at the UK Oncology Nurses Society annual conference 2016.

Cancer-Associated Thrombosis
Blood Clots Cancer and You Video

Video recording of the symposium on CAT held at the UK Oncology Nurses Society annual conference

Annual Conference on 12th November 2016.


This meeting was organised and funded by LEO Pharma. It has been deemed eligible for CPD accreditation.

WATCH AND EARN CPD CREDITS

UKONS Annual Conference 2016

Cancer patients and CAT

A patient-centred approach to management

CAThrombosis Agenda Icon

AGENDA:

Chair's Introduction, A patient's perspective

Louise O'Prey, VTE Nurse Specialist, Leeds Teaching Hospital NHS Trust

The impact of CAT on cancer patients

Eve Knight, Co-Founder and Chief Executive, AntiCoagulation Europe

The patient journey and the oncology nurses' role in the management of CAT

Professor Annie Young, Professor of Nursing, University of Warwick

All-Party Parliamentary Thrombosis Group Report Now Available to Download

The UK All-Party Parliamentary Thrombosis Group 2016 report, entitled ‘Cancer Patients – Cancer, Chemotherapy and Clots’ is now available as a downloadable PDF resource direct from CAThrombosis.com

DOWNLOAD
APPTG

Cancer-associated thrombosis (CAT), a neglected cause of cancer death: Actions needed to increase health outcomes and reduce mortality

This report summarises the findings of an Expert Steering Group meeting in Belgium

DOWNLOAD
APPTG
LEO Pharma, Denmark, has provided financial support, in the form of consultancy and secretarial services, for this report and the meeting that preceded it. The organisation of the meeting was carried out independently of this support and the company has not influenced the discussions and conclusions, which reflect, exclusively, the views of the expert participants. LEO Pharma, Denmark has reviewed this report for factual accuracy only.
LEO Logo© 2016 LEO Pharma Inc.
All rights reserved.
Date of Preparation: January 2017
Job code: UK/IE/MAT-06482 v.1
Newsletter Marketing Powered by Newsweaver